Monika Elisabeth Bjerke Svanberg
Plus aucun poste en cours
Historique de carrière de Monika Elisabeth Bjerke Svanberg
Anciens postes connus de Monika Elisabeth Bjerke Svanberg
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Springfondet Management AS
 Springfondet Management AS Investment ManagersFinance Springfondet Management AS (Springfondet) is an independent Norwegian venture capital firm which was established as a joint venture in 2005 by Forskningsparken AS (Oslo Innovation Center) and Kistefos AS. Based in the Oslo Innovation Center in Oslo, Springfondet manages the Springfondet funds, providing entrepreneurial, technology and development expertise to investee companies. | Private Equity Investor | 22/04/2009 | 30/09/2011 |
Lauras AS
 Lauras AS Miscellaneous Commercial ServicesCommercial Services Lauras AS develops drugs for immune stimulating therapy. It develops and commercializes therapeutic products, other immune deficiencies and certain types of cancer in HIV/AIDS based on proprietary technology. The company was founded by Kjetil Taskén in 1998 and is headquartered in Oslo, Norway. | Directeur/Membre du Conseil | 10/08/2009 | - |
Statistiques
Internationale
| Norvège | 3 |
Opérationnelle
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
Sectorielle
| Finance | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Springfondet Management AS
Springfondet Management AS Investment ManagersFinance Springfondet Management AS (Springfondet) is an independent Norwegian venture capital firm which was established as a joint venture in 2005 by Forskningsparken AS (Oslo Innovation Center) and Kistefos AS. Based in the Oslo Innovation Center in Oslo, Springfondet manages the Springfondet funds, providing entrepreneurial, technology and development expertise to investee companies. | Finance |
Lauras AS
Lauras AS Miscellaneous Commercial ServicesCommercial Services Lauras AS develops drugs for immune stimulating therapy. It develops and commercializes therapeutic products, other immune deficiencies and certain types of cancer in HIV/AIDS based on proprietary technology. The company was founded by Kjetil Taskén in 1998 and is headquartered in Oslo, Norway. | Commercial Services |
